» Articles » PMID: 31408707

Immune Dissociation During Acute Hepatitis E Infection

Overview
Publisher Elsevier
Date 2019 Aug 14
PMID 31408707
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We report the immune response during a case of acute HEV response in a patient with an acute hepatitis E virus (HEV) genotype 3 infection in the Netherlands.

Methods: Cytokine evaluation was performed via multiplex cytokine array for 65 immune markers in plasma during the different phases of hepatitis.

Results: The patient initially presented with features typical of acute viral hepatitis, with detectable HEV RNA in blood. This evolved into a cholestatic disease following peripheral clearance of the virus, leading to the demise of the patient. Real time PCR revealed the presence of HEV in liver tissue, suggestive of active intrahepatic infection despite clearance in blood. During the phase of detectable HEV RNA in serum, there was a surge in T-cell-related immune mediators, as well as interferon alpha and interferon gamma-induced protein 10 (IP-10), characteristic of a viral infection. After clearance of the virus in the blood and development of cholestatic hepatitis, several inflammatory markers subsided, followed by an increase in immune factors related to anti-inflammatory activity, as well as monocyte/macrophage-related markers, likely due to the intrahepatic presence of the virus.

Conclusions: This report describes the dissociation of intra- and extra-hepatic immune responses during acute HEV infection. As shedding of the virus became solely intrahepatic, an immune profile reflective of the activity of hepatic resident cells was observed.

Citing Articles

AMPK activation by hepatitis E virus infection inhibits viral replication through attenuation of autophagosomes and promotion of innate immunity.

Wang C, Liu X, Zhao Y, Liao S, Zhang J, Huang Y Cell Mol Life Sci. 2025; 82(1):111.

PMID: 40074929 PMC: 11904043. DOI: 10.1007/s00018-025-05634-8.


Hepatitis E virus: from innate sensing to adaptive immune responses.

Bruggemann Y, Klohn M, Wedemeyer H, Steinmann E Nat Rev Gastroenterol Hepatol. 2024; 21(10):710-725.

PMID: 39039260 DOI: 10.1038/s41575-024-00950-z.


Immunobiology and Host Response to HEV.

Zhou Y, Zhao H Adv Exp Med Biol. 2023; 1417:93-118.

PMID: 37223861 DOI: 10.1007/978-981-99-1304-6_7.


Review of clinical characteristics, immune responses and regulatory mechanisms of hepatitis E-associated liver failure.

Chen C, Zhang S, Chen L World J Clin Cases. 2022; 10(19):6341-6348.

PMID: 35979284 PMC: 9294909. DOI: 10.12998/wjcc.v10.i19.6341.


Hepatitis E virus infection activates NOD-like receptor family pyrin domain-containing 3 inflammasome antagonizing interferon response but therapeutically targetable.

Li Y, Yu P, Kessler A, Shu J, Liu X, Liang Z Hepatology. 2021; 75(1):196-212.

PMID: 34392558 PMC: 9299901. DOI: 10.1002/hep.32114.


References
1.
Cattoir L, Van Hoecke F, Van Maerken T, Nys E, Ryckaert I, De Boulle M . Hepatitis E virus serology and PCR: does the methodology matter?. Arch Virol. 2017; 162(9):2625-2632. DOI: 10.1007/s00705-017-3395-0. View

2.
Kamar N, Selves J, Mansuy J, Ouezzani L, Peron J, Guitard J . Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008; 358(8):811-7. DOI: 10.1056/NEJMoa0706992. View

3.
Brost S, Wenzel J, Ganten T, Filser M, Flechtenmacher C, Boehm S . Sporadic cases of acute autochthonous hepatitis E virus infection in Southwest Germany. J Clin Virol. 2009; 47(1):89-92. DOI: 10.1016/j.jcv.2009.10.011. View

4.
Stacey A, Norris P, Qin L, Haygreen E, Taylor E, Heitman J . Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol. 2009; 83(8):3719-33. PMC: 2663284. DOI: 10.1128/JVI.01844-08. View

5.
Pas S, de Man R, Mulders C, Balk A, van Hal P, Weimar W . Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg Infect Dis. 2012; 18(5):869-72. PMC: 3358074. DOI: 10.3201/eid1805.111712. View